Highlights
NASDAQ: ENDP       Endo Int'l Plc
Last Price Today's Change   Day's Range   Trading Volume
4.84   +0.02 (0.41%)  4.79 - 5.76  5,398,300

Overview

 
Avg Volume (4 weeks):7,168,035
4 Weeks Range:3.98 - 5.76
4 Weeks Price Volatility (%):
48.31%
52 Weeks Range:1.97 - 12.49
52 Weeks Price Volatility (%):
27.28%
Average Price Target: 75.00
Price Target Upside/Downside: +70.16

Headlines



No recent Headlines for this stock.


Business Background

Endo International PLC, formerly Endo Health Solutions Inc., is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm , Opana ER, Voltaren Gel, Percocet , Frova , Supprelin LA, Vantas , Valstar and Fortesta Gel. The Company operates in three segments: Endo Pharmaceuticals, Qualitest and AMS. In April 2014, the Company acquired worldwide rights to Sumavel DosePro (sumatriptan injection) for subcutaneous use, a needle-free delivery system for sumatriptan, from Zogenix, Inc. In July 2014, it acquired Grupo Farmaceutico Somar. In August 2014, Endo International PLC acquired DAVA Pharmaceuticals, Inc., a privately-held company specializing in generic pharmaceuticals.

  Be the first to like this.
 


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers